DXCM Dexcom
Permanent stock page ↗Health Care · S&P 500 · Nasdaq 100
Next earnings: not announced yet
What 29 analyst firms say about Dexcom: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
27 rated views · 30 analyst/firm records · 29 firms
Radar score
- S&P 500 · Top Picks · 6MGood · #48 in the index83
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8078
Other indices (1)
- Nasdaq 100 · Top Picks · 6MBelow the Radar threshold of 8075
- Nasdaq 100 · Safest consensus · 6MGood · #9 in the index81
Recent analyst activity · last 90 days
Our tracked history has 16 reports on DXCM from 14 analyst firms in the last 90 days (30 firms in the past year).
Comparing each firm's latest target with its previous one: 8 raised their price target, 3 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays raised its target from $64.00 (set 18 May 2026) to $120.00 on 30 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | Steve Silver | Buy | 4 Aug 2026 | 96.00 USD |
| Baird | Jeffrey D Johnson | ConflictConflicting reports · excluded | 31 Jul 2026 | 105.00 USD |
| Bank of America Securities | Travis Steed | Buy | 18 May 2026 | 80.00 USD |
| Barclays | Christopher Pasquale | Buy | 30 Oct 2026 | 120.00 USD |
| Benchmark | Bruce D. Jackson | Buy | 31 Jul 2026 | 82.00 USD |
| Bernstein | Lee Hambright | Buy | 15 May 2026 | 90.00 USD |
| BTIG | Marie Thibault | Buy | 12 Oct 2026 | 96.00 USD |
| BTIG | Ryan Zimmerman | Buy | 12 Oct 2026 | 96.00 USD |
| Canaccord Genuity | William Plovanic | Buy | 3 Aug 2026 | 90.00 USD |
| Citigroup | Joanne Wuensch | Buy | 31 Jul 2026 | 88.00 USD |
| Deutsche Bank | Kieran Ryan | Buy | 23 Jun 2026 | 86.00 USD |
| Evercore ISI | Daniel Markowitz | Buy | 31 Jul 2026 | 110.00 USD |
| Goldman Sachs | David H Roman | Buy | 8 Apr 2026 | 85.00 USD |
| Jefferies | Matthew C Taylor | Buy | 31 Jul 2026 | 115.00 USD |
| JPMorgan | Robbie Marcus | Hold | 30 Oct 2026 | 85.00 USD |
| Leerink Partners | Michael Kratky | Buy | 31 Jul 2026 | Conflicting reports · excluded |
| Mizuho | Anthony Petrone | ConflictConflicting reports · excluded | 13 Oct 2026 | 100.00 USD |
| Piper Sandler | Matt O'Brien | Buy | 31 Jul 2026 | 95.00 USD |
| Raymond James | Jayson Bedford | Buy | 30 Oct 2026 | 97.00 USD |
| RBC Capital Markets | Kendall Au | Buy | 1 Oct 2026 | 105.00 USD |
| Redburn | Issie Kirby | Buy | 1 Jun 2026 | 100.00 USD |
| Stifel | Jonathan Block | Buy | 31 Jul 2026 | 95.00 USD |
| TD Cowen | Joshua Jennings | Buy | 18 Sep 2026 | 95.00 USD |
| Truist | Richard Newitter | Buy | 30 Oct 2026 | 102.00 USD |
| UBS | Patrick Wood | Buy | 30 Oct 2026 | 107.00 USD |
| Weiss Ratings | Unnamed analyst | — | 6 Oct 2026 | — |
| Wells Fargo | Lawrence H Biegelsen | Buy | 10 Sep 2026 | 90.00 USD |
| William Blair | Steven Lichtman | Buy | 15 Oct 2026 | — |
| Wolfe Research | Mike Polark | Buy | 1 Jul 2026 | 90.00 USD |
| Data feed RESEARCH | Research Team | Hold | 12 Feb 2026 | 89.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:23 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.